Vigadrone (vigabatrin powder and tablets)
On this page
Short answer: Vigadrone is a generic vigabatrin from Upsher-Smith. The powder for oral solution (500 mg packets) was approved on 21 June 2018, and 500 mg tablets on 29 June 2023.1,2 Like Sabril, it treats infantile spasms in babies 1 month to 2 years old and, as an add-on, refractory complex partial seizures from age 2.3 It carries the same boxed warning about permanent vision loss and is dispensed only through the Vigabatrin REMS.3
What is Vigadrone?
| Form | Strength | Package | FDA approval |
|---|---|---|---|
| Vigadrone for oral solution | 500 mg packet of powder | Carton of 50 packets | ANDA 210196, 21 June 2018 |
| Vigadrone tablets | 500 mg, film-coated, scored | Bottle of 100 | ANDA 214749, 29 June 2023 |
From Drugs@FDA and the DailyMed labels.1,2,3,4
Both labels give the same uses as Sabril, word for word: infantile spasms as the only seizure medicine, and refractory complex partial seizures as an add-on that "is not indicated as a first line agent."3,4
Vigadrone vs Sabril
Vigadrone is approved through an abbreviated new drug application, the route for generics. Its powder and tablet have the same 500 mg strength as the Sabril brand.1,2
- Same medicine and uses. Both contain vigabatrin, with identical indications.3,5
- Same mixing. Both powders use 10 mL of water per packet, at 50 mg per mL, made fresh each dose.3,6
- Same warnings. Both carry the boxed warning, the same vision-check schedule and the same REMS.3
- What can differ: the maker, the support program, and how your insurance covers each.
How to mix Vigadrone powder
From the label, for each dose:3,6
- Empty each 500 mg packet into a clean cup.
- Add 10 mL of cold or room-temperature water per packet and dissolve. Doses up to 500 mg use one packet; up to 1,000 mg, two packets and 20 mL; up to 1,500 mg, three packets and 30 mL.
- Check that the solution is clear. Throw it away if it is not.
- Draw up the prescribed number of mL with an oral syringe, give it right away, and throw away the rest.
The oral syringes come separately from the pharmacy.3 The label asks prescribers to confirm that caregivers understand how to mix it and give the right dose.3 Step-by-step pictures and common mistakes are on powder sachets.
A 2025 lab study by authors from Upsher-Smith and Aucta found the mixed powder stayed stable for 48 hours in the fridge in water, juice, milk or formula. The label still says to use water and mix each dose fresh.7
Vigadrone tablets
Vigadrone tablets are white to off-white, oval, film-coated, marked "ZNV" on one side and scored on the other, in bottles of 100.4 Dosing by weight, splitting and kidney adjustments for 500 mg tablets are covered in the vigabatrin tablets guide.
Vigadrone vs the ready-to-use liquid
For babies, the alternative to mixed powder is Vigafyde, a ready-to-use liquid at 100 mg per mL. It needs no mixing, each dose is half the volume, and an opened bottle keeps 90 days. It is labeled only for infantile spasms from 1 month to 2 years.8
In one small study run by employees of Pyros, which holds the liquid's FDA application, all ready-to-use doses were within 5% of the target, while 7 of 30 mixed-powder doses missed by more than 10%. The powder in that study was Sabril, which is prepared the same way as Vigadrone.3,9 The study had real limits.
If your baby switches from powder to the liquid, the same dose is half the number of mL. Get the new volume in writing.8
Ready-to-use liquid, 100 mg/mL
7.5 mL
Drawn straight from the bottle. Fits in one 10 mL oral syringe.
Mixed powder, 50 mg/mL
15 mL
Two packets dissolved in 20 mL of water; 15 mL is given and 5 mL is thrown away. More than one 10 mL syringe-full.
Scale marks every 1 mL, 0–20 mL. Volumes from the FDA dosing tables for each product. Twice daily.
Vigadrone side effects
The Vigadrone label lists the same most common side effects as Sabril:3
- Adults: blurred vision, sleepiness, dizziness, poor coordination, tremor and fatigue.
- Children 3 to 16: weight gain.
- Babies with infantile spasms: sleepiness, bronchitis, ear infection and acute middle-ear infection.
The most serious risk is permanent loss of side vision. Vision is checked at baseline (no later than 4 weeks after starting), at least every 3 months on treatment, and about 3 to 6 months after stopping.3 Do not stop it suddenly; the label says it "should be withdrawn gradually."3
Vigadrone and the REMS
Vigadrone is available only through the shared Vigabatrin REMS Program, which covers every vigabatrin product.3,10 Prescribers must be certified, patients enrolled and pharmacies certified.8
Does Medicare cover Vigadrone?
It depends on your Medicare drug plan. Medicare.gov says "each plan has its own formulary," that is, its own list of covered drugs.11 To check, look up Vigadrone or vigabatrin on your plan's drug list, or call the plan.
- Tiers. Many plans place drugs in cost tiers, and each plan divides its tiers differently. In Medicare's example, tier 1 holds most generic drugs and a specialty tier holds very high-cost drugs. A drug in a lower tier generally costs you less.12
- Rules. A plan may need prior authorization before it covers a drug, may require step therapy, or may limit the quantity over a period.13
- Exceptions. You or your prescriber can ask the plan for an exception. The prescriber gives a statement that the drug is medically necessary.13
- Changes. Plans can change their drug lists during the year, and must tell you about changes that affect a drug you take.12
Vigadrone price, cost and coupons
We do not publish prices, because they change and what each family pays differs. What you pay depends on your plan, its tier for Vigadrone, any prior authorization, and the pharmacy. Package math and questions to ask are in our guide to vigabatrin costs.
Promise of Support. Upsher-Smith's program for Vigadrone helps from REMS enrollment to the first shipment. It checks whether a patient is covered, uninsured, needs prior authorization, or is "Eligible for the co-pay assistance program." During prior authorization it sends a starter or bridge supply. The prescription then ships from its specialty pharmacy partner.14 The program's phone line is 1-866-923-1954, Monday to Friday.14
Ask the program whether its co-pay assistance applies to your type of insurance, including Medicare or Medicaid, before you count on it. This site is independent and does not run or endorse any program.
Common questions
What is Vigadrone?
Vigadrone is a generic version of vigabatrin from Upsher-Smith. It comes as 500 mg packets of powder for oral solution and as 500 mg tablets. It treats infantile spasms in babies 1 month to 2 years old and, as an add-on, refractory complex partial seizures from age 2.
Is Vigadrone the same as Sabril?
It contains the same medicine at the same strength, has the same uses and the same boxed warning, and the powder is mixed the same way. It was approved as a generic through an abbreviated application.
Does Medicare cover Vigadrone?
It depends on the Medicare drug plan. Each plan has its own list of covered drugs, places drugs in cost tiers, and may require prior authorization. Check your plan's drug list or call the plan. You or your prescriber can ask for an exception.
How do you mix Vigadrone powder?
Empty each 500 mg packet into a clean cup and dissolve it in 10 mL of cold or room-temperature water. That makes 50 mg per mL. Draw up the prescribed dose, give it straight away, and throw away the rest.
What are Vigadrone side effects?
The same as Sabril. In adults, blurred vision, sleepiness, dizziness, poor coordination, tremor and fatigue are most common. In children 3 to 16, weight gain. In babies, sleepiness, bronchitis and ear infections. The most serious risk is permanent vision loss.
Is there a Vigadrone coupon or copay program?
Upsher-Smith's Promise of Support program checks coverage, offers co-pay assistance to eligible patients and can send a starter supply during prior authorization. Ask the program whether it applies to your insurance.
References
- 1.Drugs@FDA (openFDA): numerous ANDAs for vigabatrin for oral solution 500 mg/packet and tablets 500 mg. Examples: VIGADRONE ANDA 210196 (approved 2018-06-21; DailyMed labeler now Upsher-Smith); VIGPODER ANDA 214961 (Pyros; openFDA product: vigabatrin 500MG/PACKET, dosage form "FOR SOLUTION", route oral, TE code AA, i.e. a powder for oral solution; original approval 2022-06-24; no current DailyMed SPL found under the name Vigpoder); Teva, Amneal, Dr. Reddy's, Zydus and others. VIGAFYDE was the only vigabatrin "SOLUTION" (ready-to-use) dosage form in the results. Source
- 2.Drugs@FDA (openFDA API): ANDA 214749, vigabatrin tablet 500 mg, sponsor Upsher-Smith Labs; original approval 2023-06-29; marketing status Prescription; TE code AB. openFDA brand name for this application: VIGADRONE (Upsher-Smith Laboratories, LLC; NDC 0245-6001). Source
- 3.VIGADRONE (vigabatrin) for oral solution, revised 12/2025, Upsher-Smith. Source
- 4.VIGADRONE (vigabatrin) tablets prescribing information, Upsher-Smith Laboratories, LLC (Medication Guide revised 3/2023). ANDA 214749. Source
- 5.SABRIL (vigabatrin) tablets prescribing information, revised 10/2021. Source
- 6.SABRIL (vigabatrin) for oral solution prescribing information, revised 10/2021. Source
- 7.Zachman M, Gong L, An L, Halvorsen MB. Dissolution and stability of vigabatrin powder in water, fruit juice, milk, and infant formula. Epilepsy Behav Rep. 2025;31:100816. PMID 40838171 · DOI 10.1016/j.ebr.2025.100816 PubMedDOI
- 8.VIGAFYDE (vigabatrin) oral solution prescribing information, revised 11/2025. Source
- 9.Gibson R, Klima R, Van Horn J. Liquid Medication Dosing Errors: Comparison of a Ready-to-Use Vigabatrin Solution to Reconstituted Solutions of Vigabatrin Powder for Oral Solution. Adv Ther. 2025;42(3):1484-1493. PMID 39899223 · DOI 10.1007/s12325-024-03089-0 · PMC11868180 (Epub Feb 2025; often cited as 2024) PubMedDOI
- 11.Medicare.gov. What do drug plans cover? Source
- 12.Medicare.gov. How do drug plans work? Source
- 13.Medicare.gov. Drug plan rules. Source
- 14.Upsher-Smith. VIGADRONE Savings and Support. Source